QIAGEN acquires additional PCR licenses from Roche and Idaho Technology
The agreements cover thermal cycler rights and real-time polymerase chain reaction (PCR) methods for diagnostics and all other applications. In addition, the agreements also cover rights for "high resolution melting curve analysis" (HRM) technology. This novel PCR technology, which is well leveraged by QIAGEN's detection platform Rotor-Gene(TM) Q, opens up a broad array of applications such as mutation discovery, pathogen detection and methylation analysis, as it adds a further information dimension into traditional real time PCR.
With these agreements QIAGEN becomes the first Idaho Technology/ Roche licensee to have full freedom to offer HRM related instruments and reagents under license in all formats and for all purposes in research and diagnostics worldwide. The agreements complement previous settlement arrangements following QIAGEN's 2008 acquisition of Australian PCR cycler manufacturer Corbett.
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.